Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholelithiasis | 1 | 2024 | 23 | 0.860 |
Why?
|
| Cholecystitis, Acute | 1 | 2024 | 30 | 0.830 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2024 | 190 | 0.760 |
Why?
|
| Radiology | 1 | 2024 | 263 | 0.630 |
Why?
|
| Contrast Media | 10 | 2013 | 435 | 0.600 |
Why?
|
| Gadolinium DTPA | 4 | 2013 | 84 | 0.530 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2013 | 2324 | 0.510 |
Why?
|
| Internship and Residency | 1 | 2024 | 800 | 0.490 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2008 | 1663 | 0.410 |
Why?
|
| Diagnosis, Differential | 8 | 2024 | 993 | 0.380 |
Why?
|
| Bile Duct Diseases | 2 | 2011 | 10 | 0.360 |
Why?
|
| Pancreatic Cyst | 2 | 2005 | 22 | 0.360 |
Why?
|
| Cystic Duct | 1 | 2011 | 5 | 0.350 |
Why?
|
| Sensitivity and Specificity | 8 | 2024 | 1172 | 0.330 |
Why?
|
| Gallbladder | 2 | 2024 | 40 | 0.310 |
Why?
|
| Intussusception | 2 | 2008 | 16 | 0.310 |
Why?
|
| Radiographic Image Enhancement | 3 | 2008 | 99 | 0.260 |
Why?
|
| Ultrasonography | 3 | 2024 | 491 | 0.260 |
Why?
|
| Image Enhancement | 3 | 2007 | 196 | 0.240 |
Why?
|
| Hemangioma | 1 | 2005 | 27 | 0.220 |
Why?
|
| Diagnostic Errors | 1 | 2006 | 106 | 0.220 |
Why?
|
| Liver Neoplasms | 2 | 2005 | 310 | 0.210 |
Why?
|
| Intestines | 1 | 2006 | 184 | 0.210 |
Why?
|
| Adult | 15 | 2024 | 17579 | 0.190 |
Why?
|
| Educational Measurement | 1 | 2024 | 214 | 0.190 |
Why?
|
| Middle Aged | 14 | 2024 | 18501 | 0.180 |
Why?
|
| Education, Medical, Graduate | 1 | 2024 | 347 | 0.170 |
Why?
|
| Aged | 9 | 2024 | 15147 | 0.160 |
Why?
|
| Liver | 3 | 2013 | 875 | 0.150 |
Why?
|
| Teratoma | 1 | 1999 | 13 | 0.150 |
Why?
|
| Humans | 23 | 2024 | 65845 | 0.150 |
Why?
|
| Clinical Competence | 1 | 2024 | 731 | 0.150 |
Why?
|
| Digestive System | 1 | 1999 | 26 | 0.150 |
Why?
|
| Iohexol | 1 | 1999 | 18 | 0.150 |
Why?
|
| Gastrectomy | 1 | 1999 | 39 | 0.140 |
Why?
|
| Ovarian Neoplasms | 1 | 1999 | 170 | 0.130 |
Why?
|
| Male | 15 | 2024 | 31410 | 0.130 |
Why?
|
| Female | 15 | 2024 | 34425 | 0.130 |
Why?
|
| Retrospective Studies | 9 | 2013 | 6957 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2010 | 715 | 0.090 |
Why?
|
| Chi-Square Distribution | 2 | 2005 | 413 | 0.090 |
Why?
|
| Statistics, Nonparametric | 3 | 2008 | 213 | 0.090 |
Why?
|
| United States | 1 | 2024 | 8189 | 0.080 |
Why?
|
| Focal Nodular Hyperplasia | 1 | 2010 | 4 | 0.080 |
Why?
|
| Tomography, Spiral Computed | 1 | 2008 | 22 | 0.070 |
Why?
|
| Adolescent | 3 | 2011 | 6368 | 0.070 |
Why?
|
| Pheochromocytoma | 1 | 2007 | 31 | 0.060 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2007 | 52 | 0.060 |
Why?
|
| Urography | 1 | 2006 | 13 | 0.060 |
Why?
|
| Adipose Tissue, Brown | 1 | 2007 | 127 | 0.060 |
Why?
|
| Pulmonary Embolism | 1 | 2008 | 198 | 0.060 |
Why?
|
| Pancreatic Pseudocyst | 1 | 2005 | 12 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2011 | 5682 | 0.050 |
Why?
|
| Subtraction Technique | 1 | 2005 | 24 | 0.050 |
Why?
|
| Glass | 1 | 2023 | 23 | 0.050 |
Why?
|
| Cecal Diseases | 1 | 2003 | 4 | 0.050 |
Why?
|
| Appendiceal Neoplasms | 1 | 2003 | 9 | 0.050 |
Why?
|
| Appendix | 1 | 2003 | 17 | 0.050 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2023 | 68 | 0.050 |
Why?
|
| Thyroid Gland | 1 | 2023 | 83 | 0.050 |
Why?
|
| Mental Recall | 1 | 2023 | 95 | 0.050 |
Why?
|
| Liver Cirrhosis | 1 | 2005 | 184 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 1569 | 0.040 |
Why?
|
| Hysterosalpingography | 1 | 1999 | 4 | 0.040 |
Why?
|
| Fallopian Tube Diseases | 1 | 1999 | 6 | 0.040 |
Why?
|
| Torsion Abnormality | 1 | 1999 | 12 | 0.040 |
Why?
|
| Infarction | 1 | 1999 | 20 | 0.040 |
Why?
|
| Administration, Oral | 1 | 1999 | 371 | 0.030 |
Why?
|
| Hemorrhage | 1 | 1999 | 287 | 0.030 |
Why?
|
| Ischemia | 1 | 1999 | 203 | 0.030 |
Why?
|
| Iopamidol | 2 | 2008 | 13 | 0.030 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 1997 | 3 | 0.030 |
Why?
|
| Liver Diseases | 1 | 1998 | 157 | 0.030 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1997 | 50 | 0.030 |
Why?
|
| Peritonitis, Tuberculous | 1 | 1996 | 2 | 0.030 |
Why?
|
| Peritoneal Neoplasms | 1 | 1996 | 31 | 0.030 |
Why?
|
| ROC Curve | 2 | 2008 | 295 | 0.030 |
Why?
|
| Microsomes, Liver | 2 | 1975 | 16 | 0.030 |
Why?
|
| Carcinoma | 1 | 1996 | 130 | 0.030 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 1993 | 29 | 0.030 |
Why?
|
| Stomach | 1 | 1994 | 87 | 0.030 |
Why?
|
| Polylysine | 1 | 1993 | 49 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 1993 | 71 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2013 | 292 | 0.020 |
Why?
|
| Gadolinium | 1 | 1993 | 111 | 0.020 |
Why?
|
| Myocardium | 1 | 1993 | 302 | 0.020 |
Why?
|
| Artifacts | 2 | 2005 | 130 | 0.020 |
Why?
|
| Meglumine | 1 | 2010 | 21 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2008 | 1117 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2007 | 2500 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2010 | 92 | 0.020 |
Why?
|
| Child | 1 | 1999 | 4653 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 1975 | 465 | 0.020 |
Why?
|
| Diatrizoate Meglumine | 1 | 2008 | 6 | 0.020 |
Why?
|
| Italy | 1 | 2008 | 69 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 1993 | 922 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2008 | 183 | 0.020 |
Why?
|
| Chloroplasts | 1 | 1975 | 8 | 0.010 |
Why?
|
| Photosynthesis | 1 | 1975 | 10 | 0.010 |
Why?
|
| Streptomyces griseus | 1 | 1975 | 2 | 0.010 |
Why?
|
| Acetylglucosaminidase | 1 | 1975 | 3 | 0.010 |
Why?
|
| Hexosaminidases | 1 | 1975 | 6 | 0.010 |
Why?
|
| Hematuria | 1 | 2006 | 23 | 0.010 |
Why?
|
| Digitoxin | 1 | 1975 | 1 | 0.010 |
Why?
|
| Procaine | 1 | 1975 | 2 | 0.010 |
Why?
|
| Isocarboxazid | 1 | 1975 | 2 | 0.010 |
Why?
|
| Esterases | 1 | 1975 | 13 | 0.010 |
Why?
|
| Living Donors | 1 | 2006 | 78 | 0.010 |
Why?
|
| Streptococcus pneumoniae | 1 | 1975 | 67 | 0.010 |
Why?
|
| Amidohydrolases | 1 | 1975 | 36 | 0.010 |
Why?
|
| Time Factors | 2 | 2010 | 3779 | 0.010 |
Why?
|
| Hepatitis B, Chronic | 1 | 2005 | 5 | 0.010 |
Why?
|
| Incidence | 1 | 2008 | 1433 | 0.010 |
Why?
|
| Gastroesophageal Reflux | 1 | 1975 | 93 | 0.010 |
Why?
|
| In Vitro Techniques | 3 | 1994 | 491 | 0.010 |
Why?
|
| Hepatitis C, Chronic | 1 | 2005 | 89 | 0.010 |
Why?
|
| Hepatitis, Alcoholic | 1 | 2005 | 81 | 0.010 |
Why?
|
| Endometriosis | 1 | 2003 | 27 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 2006 | 326 | 0.010 |
Why?
|
| Diverticulitis | 1 | 2003 | 38 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2005 | 593 | 0.010 |
Why?
|
| Colitis, Ulcerative | 1 | 2003 | 76 | 0.010 |
Why?
|
| Amyloidosis | 1 | 2003 | 70 | 0.010 |
Why?
|
| Crohn Disease | 1 | 2003 | 108 | 0.010 |
Why?
|
| Kinetics | 3 | 1975 | 758 | 0.010 |
Why?
|
| Hemangioma, Cavernous | 1 | 1998 | 9 | 0.010 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1998 | 101 | 0.010 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 1997 | 5 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1998 | 175 | 0.010 |
Why?
|
| Bile Duct Neoplasms | 1 | 1997 | 60 | 0.010 |
Why?
|
| Observer Variation | 1 | 1997 | 217 | 0.010 |
Why?
|
| Pancreas | 1 | 1997 | 153 | 0.010 |
Why?
|
| Tissue Fixation | 1 | 1994 | 20 | 0.010 |
Why?
|
| Formaldehyde | 1 | 1994 | 33 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 1994 | 53 | 0.010 |
Why?
|
| Tetrazolium Salts | 1 | 1993 | 14 | 0.010 |
Why?
|
| Myocardial Reperfusion | 1 | 1993 | 23 | 0.010 |
Why?
|
| Cats | 1 | 1993 | 92 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 1994 | 81 | 0.010 |
Why?
|
| Logistic Models | 1 | 1996 | 1274 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1993 | 128 | 0.010 |
Why?
|
| Rats | 2 | 1975 | 2005 | 0.010 |
Why?
|
| Animals | 3 | 1993 | 21493 | 0.000 |
Why?
|
| Diuron | 1 | 1975 | 1 | 0.000 |
Why?
|
| Valinomycin | 1 | 1975 | 3 | 0.000 |
Why?
|
| Nigericin | 1 | 1975 | 4 | 0.000 |
Why?
|
| Digitonin | 1 | 1975 | 4 | 0.000 |
Why?
|
| Semicarbazides | 1 | 1975 | 2 | 0.000 |
Why?
|
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 1975 | 5 | 0.000 |
Why?
|
| Hydroxylamines | 1 | 1975 | 7 | 0.000 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 1975 | 24 | 0.000 |
Why?
|
| Fucose | 1 | 1975 | 5 | 0.000 |
Why?
|
| Luminescent Measurements | 1 | 1975 | 40 | 0.000 |
Why?
|
| Digitoxigenin | 1 | 1975 | 1 | 0.000 |
Why?
|
| Lasers | 1 | 1975 | 39 | 0.000 |
Why?
|
| Hydroxylation | 1 | 1975 | 10 | 0.000 |
Why?
|
| Chromatography, Thin Layer | 1 | 1975 | 16 | 0.000 |
Why?
|
| Plants | 1 | 1975 | 50 | 0.000 |
Why?
|
| NADP | 1 | 1975 | 21 | 0.000 |
Why?
|
| Subcellular Fractions | 1 | 1975 | 67 | 0.000 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1975 | 94 | 0.000 |
Why?
|
| Oligosaccharides | 1 | 1975 | 55 | 0.000 |
Why?
|
| Metals | 1 | 1975 | 65 | 0.000 |
Why?
|
| Phospholipids | 1 | 1975 | 81 | 0.000 |
Why?
|
| Methods | 1 | 1975 | 40 | 0.000 |
Why?
|
| Esophagogastric Junction | 1 | 1975 | 15 | 0.000 |
Why?
|
| Species Specificity | 1 | 1975 | 344 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1975 | 105 | 0.000 |
Why?
|
| Manometry | 1 | 1975 | 28 | 0.000 |
Why?
|
| Esophagus | 1 | 1975 | 47 | 0.000 |
Why?
|
| Pressure | 1 | 1975 | 80 | 0.000 |
Why?
|
| Structure-Activity Relationship | 1 | 1975 | 357 | 0.000 |
Why?
|
| Deglutition Disorders | 1 | 1975 | 44 | 0.000 |
Why?
|
| Temperature | 1 | 1975 | 317 | 0.000 |
Why?
|
| Proteins | 1 | 1975 | 764 | 0.000 |
Why?
|